ABVC BioPharma, Inc. Convertible Notes Payable, Noncurrent
ABVC BioPharma, Inc. (ABVC) had Convertible Notes Payable, Noncurrent of $1.65 million as of 2023-09-30, per its 10-Q filed 2023-11-15.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt and Lease Obligation › Notes and Loans, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2023-11-15
- 2023-09-30: Convertible Notes Payable, Noncurrent $1.65M.
- 2023-06-30: Convertible Notes Payable, Noncurrent $3.30M.
- 2023-03-31: Convertible Notes Payable, Noncurrent $3.21M.
- 2021-06-30: Convertible Notes Payable, Noncurrent $2.50M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2023-09-30 | $1.65M 10-Q · filed 2023-11-15 |
| 2023-06-30 | $3.30M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.21M 10-Q · filed 2023-05-15 |
| 2021-06-30 | $2.50M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.50M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $2.50M 10-K · filed 2022-03-31 |
| 2018-09-30 | $300.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $300.00K 10-Q · filed 2018-08-20 |